Propeller Health and Boehringer Ingelheim announced a new commercial partnership. Under the partnership, COPD and asthma patients using Boehringer’s Respimat inhaler will have the opportunity to enroll in a program at select health systems that will monitor their adherence via a Propeller sensor and improve their engagement in their health.
“So far we have developed a popular Bluetooth-enabled sensor that wraps around the Respimat device,” Ruchin Kansal, executive director and head of business innovation at BI. “It’s a proprietary soft mist platform that has been shown to be highly effective in delivery of medication for the patient. What this sensor allows is to actively track patient behavior around their medication. And through that tracking, it can create a dialogue with the patient or connect the patient and the provider to a support service. The object of our current partnership is to create some of the real-world market experience of our technology so the providers will be willing to provide it, the patients will be willing to adopt a sensor and basically drive adherence.” For the full article click here
from health IT caucus http://ift.tt/22xYuI0
via IFTTT
No comments:
Post a Comment